Sanara MedTech (SMTI) reported Q4 preliminary revenue late Tuesday of $25.7 million to $26.2 million, up 45% to 48% from a year earlier.
Two analysts polled by FactSet expect $22.8 million.
The company said it had cash of $15.9 million as of Dec. 31, compared with $16.3 million as of Sept. 30.
Sanara MedTech appointed Elizabeth Taylor as chief financial officer, succeeding Michael McNeil, who was named chief accounting officer and chief administrative officer.
The appointments were effective Jan. 15, the company said Tuesday in a statement.
Taylor most recently served as CFO of Imbed Biosciences.
Sanara MedTech shares rose 9.7% in recent after-hours activity.
Price: 37.28, Change: +3.28, Percent Change: +9.65
Comments